Menu

Blog

Archive for the ‘biotech/medical’ category: Page 1400

Mar 29, 2021

Evolution drives autism and other conditions to occur much more frequently in boys

Posted by in categories: biotech/medical, evolution, genetics, health, neuroscience

In autism, male-female imbalance is especially pronounced. Boys are as much as four times more likely to have some form of autism and are also more likely to have severe symptoms.


HAMILTON, ON, March 3, 2021 — Evolutionary forces drive a glaring gender imbalance in the occurrence of many health conditions, including autism, a team of genetics researchers has concluded.

The human genome has evolved to favour the inheritance of very different characteristics in males and females, which in turn makes men more vulnerable to a host of physical and mental health conditions, say the researchers responsible for a new paper published in the Journal of Molecular Evolution.

Continue reading “Evolution drives autism and other conditions to occur much more frequently in boys” »

Mar 29, 2021

Roundworms ‘read’ wavelengths in the environment to avoid dangerous bacteria that secrete colorful toxins

Posted by in categories: biotech/medical, nanotechnology

Roundworms don’t have eyes or the light-absorbing molecules required to see. Yet, new research shows they can somehow sense color. The study, published in the journal Science, suggests worms use this ability to assess the risk of feasting on potentially dangerous bacteria that secrete blue toxins. The researchers pinpointed two genes that contribute to this spectral sensitivity and are conserved across many organisms, including humans.

“It’s amazing to me that a —with neither eyes nor the molecular machinery used by eyes to detect colors—can identify and avoid a toxic bacterium based, in part, on its ,” says H. Robert Horvitz, the David H. Koch Professor of Biology at MIT, a member of the McGovern Institute for Brain Research and the Koch Institute for Integrative Cancer Research, Howard Hughes Medical Institute Investigator, and the co-senior author of the study. “One of the joys of being a biologist is the opportunity to discover things about nature that no one has ever imagined before.”

The roundworm in question, Caenorhabditis elegans, is only about a millimeter long. Despite their minute stature and simple nervous system, these nematodes display a complex repertoire of behaviors. They can smell, taste, sense touch, react to temperature, and even escape or change their feeding patterns in response to bright, . Although researchers once thought that these bury themselves deep in soil, it’s becoming increasingly clear that C. elegans prefers compost heaps above ground that offer some sun exposure. As a result, roundworms may have a need for light-and color-sensing capabilities after all.

Mar 29, 2021

Life Expectancy Falling for Adults Without a Bachelor’s Degree

Posted by in categories: biotech/medical, education

Summary: Since 2010, there has been an absolute rise in mortality for adults without a college degree. For those with higher education experience, mortality rates have decreased during the same time period.

Source: Princeton University.

Life expectancy in the United States dropped in 2020 due to COVID-19, but, for American adults without a college degree, the increase in mortality in adulthood occurred even earlier, according to a new study authored by Anne Case and Sir Angus Deaton of Princeton University.

Mar 29, 2021

This L.A. start-up is building tiny injectable robots to attack tumors

Posted by in categories: biotech/medical, chemistry, robotics/AI

Doctors take a microscopic craft loaded with cancer-killing chemicals, inject it into the human body, and drive it to a malignant tumor to deliver its payload before making a quick exit. The plan is to move to clinical trials by 2023.


Chemotherapy and radiation can cause too much collateral damage to treat some brain tumors. Crumb-sized robots could be the solution.

Mar 29, 2021

Biotech Companies Seek to Restore Functions to Spinal-Cord Injury Patients

Posted by in category: biotech/medical

Biotechnology companies and researchers are studying treatments that could help patients with spinal-cord injuries recover abilities to move and function that they have lost.


WSJ Membership.

Mar 29, 2021

Scientists are weaponizing viruses to solve a huge problem

Posted by in categories: bioengineering, biotech/medical

Now scientists are hoping to use the knowledge about CRISPR systems to engineering phages to destroy dangerous bacteria.


As the world fights the SARS-CoV-2 virus causing the COVID-19 pandemic, another group of dangerous pathogens looms in the background.

Mar 29, 2021

Study finds cancer cells may evade chemotherapy

Posted by in categories: biotech/medical, health

In the study, the researchers found that when AML cells were exposed to chemotherapy, a subset of the cells went into a state of hibernation, or senescence, while at the same time assuming a condition that looked very much like inflammation. They looked similar to cells that have undergone an injury and need to promote wound healing—shutting down the majority of their functions while recruiting immune cells to nurse them back to health.


Cancer cells can dodge chemotherapy by entering a state that bears similarity to certain kinds of senescence, a type of “active hibernation” that enables them to weather the stress induced by aggressive treatments aimed at destroying them, according to a new study by scientists at Weill Cornell Medicine. These findings have implications for developing new drug combinations that could block senescence and make chemotherapy more effective.

In a study published Jan. 26 in Cancer Discovery, a journal of the American Association for Cancer Research, the investigators reported that this biologic process could help explain why cancers so often recur after treatment. The research was done in both organoids and mouse models made from patients’ samples of acute myeloid leukemia (AML) tumors. The findings were also verified by looking at samples from AML patients that were collected throughout the course of treatment and relapse.

Continue reading “Study finds cancer cells may evade chemotherapy” »

Mar 29, 2021

FDA Approves VA-Made 3D-Printed Hearing Device for South Carolina Veteran

Posted by in category: biotech/medical

“3D printing—I think the majority of what it does is allow us to make individualized treatment, when we never had that opportunity to do it before,” Ripley explained. “And I think we’re going to just keep growing with that.”


It’s rooted in the patient’s unique idea to use a drinking straw to open up his hearing pathway.

Mar 29, 2021

We Finally Know How Sperm ‘Remember’ And Pass on Non-DNA-Coded Traits to Embryos

Posted by in categories: biotech/medical, genetics

Studies in mammals have shown that the ‘memories’ of various environmental effects – such as diet, weight, and stress – are being passed on from dads to offspring, despite these states not being coded for in the DNA sequences carried by sperm. Now, we have a new explanation for how it’s possible.

The story has much to do with epigenetics. Molecules that attach themselves to DNA can act like on-off switches that control which sections of DNA get used – but until now we haven’t known which of these molecules can carry the settings marked by a father’s life experiences, to be incorporated into an embryo via sperm.

“The big breakthrough with this study is that it has identified a non-DNA-based means by which sperm remember a father’s environment (diet) and transmit that information to the embryo,” said McGill University epigeneticist Sarah Kimmins.

Mar 29, 2021

Sangamo, Sanofi Show Positive Early Data for SCD Gene-Edited Cell Therapy

Posted by in categories: biotech/medical, genetics

An ex vivo gene-edited cell therapy for sickle cell disease (SCD) being developed by Sangamo Therapeutics and Sanofi has generated positive early Phase I/II results in three patients—data that persuaded a committee of the European Medicines Agency (EMA) to support an orphan designation for the drug candidate.

The EMA’s Committee for Orphan Medicinal Products (COMP) has adopted a positive opinion for the orphan designation for BIVV003 (autologous CD34+ hematopoietic stem and progenitor cells transfected with zinc finger nuclease mRNAs SB-mRENH1 and SB-mRENH2) following its meeting of January 19–21— minutes of which were posted this month on the EMA’s website.

COMP based its recommendation on data showing that the first three patients with sickle cell disease ended up “without recurrence of previous SCD symptoms” following treatment with BIVV003 in the Phase I/II PRECIZN-1 trial (NCT03653247).